RxSight, Inc.
Clinical trials sponsored by RxSight, Inc., explained in plain language.
A medical device company specializing in adjustable intraocular lenses for cataract surgery.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Adjustable lens study tracks Long-Term vision results Results expected Sep 2026 (estimated)